Petrus Bekker, Chief Medical Officer at ChemoCentryx, Inc. (CCXI), sold 83,009 shares at $9.12 ($760K) on 2017-06-28, disclosed to the SEC on 2017-06-30.
Open-market sale of $760k CCXI by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.12 | 30,000 | $274K | 36.0% |
| 2 | $9.11 | 5,509 | $50K | 6.6% |
| 3 | $9.11 | 5,509 | $50K | 6.6% |
| 4 | $9.12 | 11,991 | $109K | 14.4% |
| 5 | $9.12 | 11,991 | $109K | 14.4% |
| 6 | $9.30 | 18,009 |
| $167K |
| 22.0% |
| Total | $9.16 avg | 83,009 | $760K | 100% |
| Filing → |
| CCXI | SELL | 2016-12-20 | $134K | — | Filing → |
| CCXI | SELL | 2016-12-07 | $255K | — | Filing → |
| CCXI | SELL | 2016-11-23 | $10K | — | Filing → |